USANA Health Sciences, Inc.
USNA
$17.05
-$0.09-0.52%
NYSE
| 01/03/2026 | 09/27/2025 | 06/28/2025 | 03/29/2025 | 12/28/2024 | |
|---|---|---|---|---|---|
| Revenue | 8.28% | 5.88% | 2.75% | -2.69% | -7.22% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.28% | 5.88% | 2.75% | -2.69% | -7.22% |
| Cost of Revenue | 24.59% | 15.17% | 7.24% | -0.38% | -8.76% |
| Gross Profit | 4.49% | 3.68% | 1.69% | -3.23% | -6.86% |
| SG&A Expenses | 8.86% | 9.43% | 5.11% | 0.28% | -4.99% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.11% | 10.64% | 5.56% | 0.14% | -5.80% |
| Operating Income | -31.79% | -39.19% | -23.59% | -27.87% | -19.88% |
| Income Before Tax | -45.61% | -48.37% | -31.62% | -34.71% | -25.48% |
| Income Tax Expenses | -12.37% | -20.86% | -24.40% | -20.33% | -11.31% |
| Earnings from Continuing Operations | -72.71% | -67.69% | -36.78% | -43.80% | -34.06% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -2,290.00% | -- | -- | -- | -- |
| Net Income | -74.40% | -68.74% | -38.06% | -43.67% | -34.11% |
| EBIT | -31.79% | -39.19% | -23.59% | -27.87% | -19.88% |
| EBITDA | -6.38% | -18.50% | -9.64% | -17.57% | -15.76% |
| EPS Basic | -74.46% | -68.56% | -37.13% | -43.14% | -33.55% |
| Normalized Basic EPS | -34.60% | -39.52% | -23.07% | -25.77% | -16.77% |
| EPS Diluted | -74.69% | -68.91% | -37.24% | -43.46% | -33.79% |
| Normalized Diluted EPS | -34.46% | -39.40% | -22.81% | -25.56% | -16.76% |
| Average Basic Shares Outstanding | -2.97% | -2.11% | -1.30% | -0.89% | -0.87% |
| Average Diluted Shares Outstanding | -3.17% | -2.32% | -1.66% | -1.19% | -0.95% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |